Phathom Pharmaceuticals Inc
PHATNASDAQStock · Data from SEC EDGAR 13F · Held by 3 of 87 tracked investors
Phathom Pharmaceuticals Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation95
- Growth95
- Profitability10
- Quality25
- Debt15
- Stability60
- ✓Revenue grew 1,502.4% a year over 2 years.
- ✓The stock is cheaper: you pay 6.2 USD for 1 USD of annual earnings.
- ✓The analysts' average target is 228% above the price.
- !The company is loss-making: net profit is negative.
- !Free cash flow is negative and the company has debt.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
Fairly cheapThe company has no earnings, so the P/E cannot be calculated.
- P/E
- –
- P/S
- 2.0×
- EV/EBITDA
- -21.2×
Is the company growing?
GrowingRevenue over 2 years grew 1,502.4% a year. Last year 88.0%.
Does it make money?
Loss-making- Cost of sales 13
Earnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 30 Jul 2026 | -0.08 | -0.15 | +46.7% |
| Mar 2026 | 30 Apr 2026 | -0.25 | -0.27 | +7.4% |
| Dec 2025 | 26 Feb 2026 | -0.16 | -0.20 | +20% |
| Sep 2025 | 30 Oct 2025 | -0.28 | -0.40 | +30% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart PHAT
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
3PF Pale Fire Capital Pale Fire Capital SE | 0.04% |
SC Steven Cohen Point72 Asset Management | 0.01% |
IE Israel Englander Millennium Management | 0.01% |
Frequently asked questions
How much is Phathom Pharmaceuticals Inc (PHAT) stock?
Phathom Pharmaceuticals Inc shares trade at $5.99, +0.84% over the last trading day. The price is delayed.
What is the market cap of Phathom Pharmaceuticals Inc?
The market cap of Phathom Pharmaceuticals Inc is about $485M.
Which big investors hold Phathom Pharmaceuticals Inc?
According to the latest 13F filings, 3 of 87 tracked investors hold Phathom Pharmaceuticals Inc, for example Pale Fire Capital, Steven Cohen, Israel Englander.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.